Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (8725)	4/6/2001 11:35:50 AM
From: scaram(o)uche	Respond to of 9719

Cary: Not really certain what you're asking. A physician will occasionally submit a proposal for funding for what becomes known as a "physician-sponsored IND". Yes, it's tough to get NIH funding, but the level of "tough" varies from one NIH department to the next. Is this sort of thing rare? Not particularly, but, again, I'm not clear what you're really inquiring about. Rick

To: Arthur Radley who wrote (8725)	4/6/2001 10:29:08 PM
From: Biomaven	Read Replies (1) \| Respond to of 9719

TexasDude, There's a big difference between Phase I and Phase II grants. Phase II generally means they achieved something real in a Phase I. In general, NIH funding is very important for a lot of small biotech startups. $1 million does seem like more than I generally recall most small companies getting, though. There's a searchable database (CRISP) that lets you find all grants. commons.cit.nih.gov Incidentally, I don't believe the analog of NIH grants exists elsewhere in the world. Other countries fund "pure" research, but not (that I am aware of) stuff that is intended to eventually make money. Peter